Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
“Increased production of growth factors” refers generally to a state in which cells or tissues produce higher-than-normal amounts of growth factor proteins. Growth factors are a broad class of secreted peptides and proteins (such as EGF, FGF, VEGF, PDGF, TGF-beta, and others) that regulate cellular proliferation, survival, differentiation, and tissue repair via binding to specific receptors (often receptor tyrosine kinases) on the target cell surface. While regulated production is crucial for homeostasis, tissue repair, and development, pathologically increased production is frequently observed in cancer, chronic inflammation, and fibrosis, resulting in excessive cell proliferation and other maladaptive responses. “Increased production of growth factors” is a pathological mechanism, not a discrete molecular entity
Inhibitors of specific growth factor receptors (e.g., tyrosine kinase inhibitors, monoclonal antibodies) Downregulation or neutralization of growth factor signaling pathways
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Increased production of growth factors.